Vaerlose, Denmark

Schneur Rachlin


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Vaerlose, DK (1981 - 1993)
  • V.ae butted.rl.o slashed.se, DK (1996)
  • H.o slashed.rsholm, DK (1999)

Company Filing History:


Years Active: 1981-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Schneur Rachlin

Introduction: Schneur Rachlin, located in Vaerlose, Denmark, is an accomplished inventor known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Rachlin has made strides in developing compounds that target important biological pathways.

Latest Patents: Among his latest innovations are two noteworthy patents: "Quinoline derivatives containing a diol as leukotriene antagonists" and "Isoserine derivatives and their use as leukotriene antagonists." These inventions reflect his dedication to advancing medical science by providing new therapeutic options for managing inflammatory conditions.

Career Highlights: Rachlin has worked with notable companies in the pharmaceutical sector, including Leo Pharmaceutical Products, Ltd. and Leo Pharmaceutical Products A/S (Lovens Kemiske Fabrik). His experience in these organizations has allowed him to refine his expertise and contribute to various projects aimed at improving patient outcomes.

Collaborations: Throughout his career, Rachlin has collaborated with esteemed colleagues, including Dorte Kirstein and Erik T. Hansen. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas, essential for pushing the boundaries of pharmaceutical research.

Conclusion: Schneur Rachlin's impressive portfolio of patents and his extensive work in the pharmaceutical industry underline his status as a key inventor in the field. His contributions have not only enhanced our understanding of leukotriene antagonism but also provided new avenues for therapeutic development. As he continues to innovate, the impact of his work will undoubtedly resonate within the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…